Concepedia

Author

Narinder Nangia

Alkermes (United States)ORCID

Also Known As

N. Nangia, Narinder K. Nangia, Narinder Nangia

23

Publications

461

Citations

11

H-Index

19

Concepts

All Affiliations

Alkermes (United States)University of TorontoSyneos Health (United States)Duke Medical CenterAltasciences Clinical Research Vince & Associates
NN

About

Narinder Nangia is an author at Alkermes (United States) specializing in pain research, pain management, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Business

1

1

20

2

Health Sciences

1

1

78

3

Medicine

1

1

78

4

Public Health

1

1

20

5

Economics

1

1

20

Narinder Nangia

×

11

Publications

441

Citations

11

H-Index

YearCitations

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy

Samer K. Khaled, Kathleen Claes, Yeow Tee Goh,

Journal of Clinical Oncology

2022

87

Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial

Teresa L. Coats, David Borenstein, Narinder Nangia,

Clinical Therapeutics

2004

78

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies

Maurizio Fava, Michael E. Thase, Madhukar H. Trivedi,

Molecular Psychiatry

2018

77

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

Robert T. Naismith, Jerry S. Wolinsky, Annette Wundes,

Multiple Sclerosis Journal

2019

62

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial

Adam Bisaga, Paolo Mannelli, Miao Yu,

Drug and Alcohol Dependence

2018

47

Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism

Edward V. Nunes, Adam Bisaga, Evgeny Krupitsky,

Addiction

2019

21

Estimation of Median Income of Four-Person Families: A Bayesian Time Series Approach

Malay Ghosh, Narinder Nangia, Dal Ho Kim

Journal of the American Statistical Association

1996

20

Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study

Lei Sun, Sergey Yagoda, Hongqi Xue,

Progress in Neuro-Psychopharmacology and Biological Psychiatry

2020

14

Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial

Sanjeev Pathak, Bradley Vince, Debra Kelsh,

The Journal of Clinical Pharmacology

2018

12

Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study

Sanjeev Pathak, Bradley Vince, Debra Kelsh,

The Journal of Clinical Pharmacology

2018

12

Page 1